Enfuvirtide Resistance Mutations: Impact on Human Immunodeficiency Virus Envelope Function, Entry Inhibitor Sensitivity, and Virus Neutralization

Enfuvirtide (ENF/T-20/Fuzeon), the first human immunodeficiency virus (HIV) entry inhibitor to be licensed, targets a structural intermediate of the entry process. ENF binds the HR1 domain in gp41 after Env has bound CD4, preventing conformational changes needed for membrane fusion. Mutations in HR1...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Reeves, Jacqueline D., Lee, Fang-Hua, Miamidian, John L., Jabara, Cassandra B., Juntilla, Marisa M., Doms, Robert W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2005
Ämnen:
Vaccines and Antiviral Agents
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1069568/
https://ncbi.nlm.nih.gov/pubmed/15795284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.8.4991-4999.2005
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk